Snehal Srikrishna

• Report to President of Global Quality Cloud business (T-1): $460M+ ACV and ~$120M+ Services revenue
• "GM leader" responsible for growth strategy across key vertical markets, industry thought leadership, customer engagement, and GTM motion across major life sciences segments totaling $1.1Bn+ TAM
• One of 15 "core GM leaders" across Veeva for managing strategic executive relationships with Top 25 global Pharma customers including hosting Annual Veeva Executive Forum and Veeva Summits globally
• Ownership of business planning processes for defining 5-year Growth Plans, setting annual Hill to Climb objectives, and leading annual Field Kick Off enablement sessions for Sales and Strategy
• Lead GTM execution with field facing leaders across Sales, Strategy, Marketing, Solution Consulting, Services through weekly cross team meetings to review key deals, key hires, and key projects
• Plan and execute "Innovation Days" with 3-5 strategic customers annually to jointly define a vision and build a longer range roadmap
• Manage 12 member “virtual CEO” team owning Veeva’s cloud solutions for R&D & Quality across Top 50 Global Pharma, CMOs & Generics, Asia, and India segments
• Developed strategy and competitive positioning on application of advanced automation / AI in life sciences; navigated hype vs reality on high value use cases for GenAI and established AI partner program
• Developed ecosystem of strategic partners including management consulting firms to enable customer success during implementations and post-implementation of Veeva’s applications
• Recognition through "deal of the year" team awards at Amgen, Pfizer, and Teva

Start-up Experience: In addition to above, built and scaled four “start-up” businesses from Zero to One for new product launch and new vertical markets including:

• Data/AI (Oct 2024 - present): Launched Veeva AI across 600+ customers in US and Europe
• Enterprise 32 (Feb 2023 – Sep 2024): Hired 10+ sales team and strategy leads to accelerate growth to 30%+ yoy
• India (Feb 2021 – Sep 2024): Hired GM, Sales leader, and Services leader to scale business to $10M+ ARR and 25+ team
• Generics & CDMO (Sep 2019 – Jan 2021): Hired Sales leader and built 20+ Sales team; acquired 30 customers in US and Europe and scaled business to $50M+ ARR

• Practice Leader: Managed 20+ consulting team serving US life sciences clients' strategic priorities in R&D, Technical Operations, and GxP Quality. Exceeded $6M/yr revenue managed target in 2017-19.
• Business Development: Prospected and acquired new business as member of Operations TransformationLT.Exceeded$8M/yr sales target for 2016-19.
• Thought leadership: Established Top 25 Pharma Heads of R&D Quality and Heads of QMS Roundtables (2017-19)
• India: Established PRTM's consulting business (acquired by PwC); built and scaled a 50+ member India Analytics team. Transferred as Multi-national Executive (EB1-A visa) to build the US West Coast life sciences market
• R&D: Slashed development costs and accelerated clinical development programs by 50% at Roivant by implementing PlanisWare
• R&D: Reduced cycle times for submissions and HA approval of registrations by 35% at Amgen by implementing Veeva Vault RIM
• R&D: Technology Transfer and remediation of 70+ molecules for Hospira (Pfizer) from US to India R&D site to achieve target volume and velocity of development projects and ANDA filings
• Technical Operations: Streamlined CMC processes for drug substance and drug product mfg.by 25% for therapeutics portfolio at the Bill & Melinda Gates Foundation
• Technical Operations: End-to-end operations program management (Man in Plant) for build-out, operational readiness, and tech transfer of 13 molecules to Hospira's largest sterile injectables mfg. site in India
• Quality: Unlocked synergies from GxP integration and harmonization as part of merger of Shire & Baxalta; implemented Vault QualityDocs
• Quality: Unlocked synergies from GxP harmonization as part of merger of BMS and Celgene; implemented Vault QualityDocs
• India Quality: Quality systems remediation & organization redesign for Ranbaxy (Sun Pharma) to overcome Injunction/Consent Decree and Import Alert at 3 sites
• Supply Chain: Realized 12% reduction in COGS via tax-efficient principal in Singapore to source materials at CR Bard (SAP)
• Commercial: Improved compliance and efficiency of CMLR processes globally by implementing Vault PromoMats
• Promoted 4 times: Senior Associate (2011), Manager (2012), Senior Manager (2014), and Director (2016)
• Admitted as a Junior Partner to PwC’s Partnership Candidate Leadership Development program (2018)

• Undertook interim-management of the family business providing CFO-on-hire and other advanced financial services for small and medium companies in South India
• Executed strategic sale and transfer of business ownership in Dec 2009

• Streamlined end-to-end Supply Chain processes for multi-year enterprise technology deployments at Astellas, Takeda, and EMD Serono
• Program managed deployments of Ariba (Procure to Pay), Siemens PLM (Design to Make), and i2 (Plan to Deliver)
• Co-authored 2008 Global Innovation Study based on 500+ executive survey across 30+ countries

• Secured USAF Grant for predictive aircraft maintenance using Ultrasonic NDE
• Developed neural network algorithms for 3D visualization of fractures